Literature DB >> 19372662

Molecular imaging with targeted contrast ultrasound.

Mark Piedra1, Achim Allroggen, Jonathan R Lindner.   

Abstract

Molecular imaging with contrast-enhanced ultrasound uses targeted microbubbles that are retained in diseased tissue. The resonant properties of these microbubbles produce acoustic signals in an ultrasound field. The microbubbles are targeted to diseased tissue by using certain chemical constituents in the microbubble shell or by attaching disease-specific ligands such as antibodies to the microbubble. In this review, we discuss the applications of this technique to pathological states in the cerebrovascular system including atherosclerosis, tumor angiogenesis, ischemia, intravascular thrombus, and inflammation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372662      PMCID: PMC7065399          DOI: 10.1159/000203128

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  35 in total

1.  Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration.

Authors:  Jonathan R Lindner; Ji Song; Ananda R Jayaweera; Jiri Sklenar; Sanjiv Kaul
Journal:  J Am Soc Echocardiogr       Date:  2002-05       Impact factor: 5.251

2.  Nanoparticles as image enhancing agents for ultrasonography.

Authors:  Jun Liu; Andrea L Levine; John S Mattoon; Mamoru Yamaguchi; Robert J Lee; Xueliang Pan; Thomas J Rosol
Journal:  Phys Med Biol       Date:  2006-04-10       Impact factor: 3.609

3.  Optical and acoustical observations of the effects of ultrasound on contrast agents.

Authors:  P A Dayton; K E Morgan; A L Klibanov; G H Brandenburger; K W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  1999       Impact factor: 2.725

4.  In vitro studies of a new thrombus-specific ultrasound contrast agent.

Authors:  E C Unger; T P McCreery; R H Sweitzer; D Shen; G Wu
Journal:  Am J Cardiol       Date:  1998-06-18       Impact factor: 2.778

5.  Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression.

Authors:  Howard Leong-Poi; Jonathan Christiansen; Peter Heppner; Christopher W Lewis; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

6.  Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis.

Authors:  Feng Xie; Jeane M Tsutsui; John Lof; Evan C Unger; Jason Johanning; William C Culp; Terry Matsunaga; Thomas R Porter
Journal:  Ultrasound Med Biol       Date:  2005-07       Impact factor: 2.998

7.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.

Authors:  Gregory E R Weller; Michael K K Wong; Ruth A Modzelewski; Erxiong Lu; Alexander L Klibanov; William R Wagner; Flordeliza S Villanueva
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

8.  Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.

Authors:  Moritz Palmowski; Jochen Huppert; Gesa Ladewig; Peter Hauff; Michael Reinhardt; Margareta M Mueller; Eva C Woenne; Juergen W Jenne; Mathias Maurer; Guenter W Kauffmann; Wolfhard Semmler; Fabian Kiessling
Journal:  Mol Cancer Ther       Date:  2008-01       Impact factor: 6.261

9.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

10.  The binding of cationic probes to apical and basal surfaces of rat lung capillary endothelium and of endothelial cells in tissue culture.

Authors:  S Rounds; C A Vaccaro
Journal:  Am Rev Respir Dis       Date:  1987-03
View more
  6 in total

1.  Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.

Authors:  Christopher R Anderson; Xiaowen Hu; Hua Zhang; Jose Tlaxca; Anne-Emilie Declèves; Robert Houghtaling; Kumar Sharma; Michael Lawrence; Katherine W Ferrara; Joshua J Rychak
Journal:  Invest Radiol       Date:  2011-04       Impact factor: 6.016

Review 2.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

3.  Contrast-enhanced ultrasound molecular imaging of activated platelets in the progression of atherosclerosis using microbubbles bearing the von Willebrand factor A1 domain.

Authors:  Jie Tian; Yahui Weng; Ruiying Sun; Ying Zhu; Jun Zhang; Hongyun Liu; Yani Liu
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

Review 4.  Contrast-enhanced ultrasound: clinical applications in patients with atherosclerosis.

Authors:  Arend F L Schinkel; Mathias Kaspar; Daniel Staub
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-24       Impact factor: 2.357

5.  RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.

Authors:  Qiao Hu; Xiao-Yan Wang; Li-Ke Kang; Hai-Ming Wei; Chun-Mei Xu; Tao Wang; Zong-Hua Wen
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 6.  Multimodal Molecular Imaging: Current Status and Future Directions.

Authors:  Min Wu; Jian Shu
Journal:  Contrast Media Mol Imaging       Date:  2018-06-05       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.